Abcellera Biologics Inc (ABCL)

Dec 20, 2024

AbCellera Biologics (NASDAQ:ABCL) Stock Price Up 3.3%Still a Buy? - MarketBeat

Dec 20, 2024

Dec 14, 2024

AbCellera Biologics (NASDAQ:ABCL) Shares Gap UpHere's What Happened - MarketBeat

Dec 14, 2024

Dec 08, 2024

Walleye Capital LLC Makes New $668,000 Investment in AbCellera Biologics Inc. (NASDAQ:ABCL) - MarketBeat

Dec 08, 2024

Dec 07, 2024

AbCellera Biologics (FRA:8QQ) Price-to-Owner-Earnings : (As of Dec. 07, 2024) - GuruFocus.com

Dec 07, 2024

Dec 05, 2024

PDT Partners LLC Sells 173,884 Shares of AbCellera Biologics Inc. (NASDAQ:ABCL) - MarketBeat

Dec 05, 2024

Dec 04, 2024

AbCellera's SWOT analysis: biotech firm's stock faces pivotal year By Investing.com - Investing.com Canada

Dec 04, 2024

Dec 04, 2024

AbCellera's SWOT analysis: biotech firm's stock faces pivotal year - Investing.com India

Dec 04, 2024

Nov 28, 2024

AbCellera Biologics (FRA:8QQ) Degree of Operating Leverage : -1.44 (As of Sep. 2024) - GuruFocus.com

Nov 28, 2024

Nov 26, 2024

ABCL (AbCellera Biologics) Net Issuance of Debt : $3.95 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

ABCL (AbCellera Biologics) Pre-Tax Income : $-202.17 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

ABCL (AbCellera Biologics) Capex-to-Revenue : 2.85 (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

ABCL (AbCellera Biologics) Buildings And Improvements : $66.92 Mil (As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 26, 2024

ABCL (AbCellera Biologics) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 26, 2024

Nov 24, 2024

ABCL (AbCellera Biologics) Revenue per Share : $0.11 (TTM As of Sep. 2024) - GuruFocus.com

Nov 24, 2024

Nov 23, 2024

ABCL (AbCellera Biologics) Change In Receivables : $-64.70 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 23, 2024

Nov 23, 2024

ABCL (AbCellera Biologics) Debt-to-Equity : 0.07 (As of Sep. 2024) - GuruFocus.com

Nov 23, 2024

Nov 22, 2024

ABCL (AbCellera Biologics) Owner Earnings per Share (TTM) : -0.61 (As of Sep. 2024) - GuruFocus.com

Nov 22, 2024

Nov 22, 2024

AbCellera to Present at Upcoming Investor Conferences in December and January - Devon Dispatch

Nov 22, 2024

Nov 21, 2024

AbCellera to Present at Major Healthcare Conferences: Piper Sandler and JPM 2024-25 - StockTitan

Nov 21, 2024

Nov 20, 2024

ABCL (AbCellera Biologics) Goodwill-to-Asset : 0.03 (As of Sep. 2024) - GuruFocus.com

Nov 20, 2024

Nov 20, 2024

ABCL (AbCellera Biologics) EBIT per Share : $-1.00 (TTM As of Sep. 2024) - GuruFocus.com

Nov 20, 2024

Nov 19, 2024

GSA Capital Partners LLP Boosts Stock Position in AbCellera Biologics Inc. (NASDAQ:ABCL) - MarketBeat

Nov 19, 2024

Nov 13, 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Shares Sold by Baillie Gifford & Co. - MarketBeat

Nov 13, 2024

Nov 11, 2024

AbCellera Biologics (NASDAQ:ABCL) Sees Strong Trading VolumeShould You Buy? - MarketBeat

Nov 11, 2024

Nov 08, 2024

Bloom Burton Cuts Earnings Estimates for AbCellera Biologics - MarketBeat

Nov 08, 2024

Nov 07, 2024

Adv Micro Devices (AMD-Q) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Abcellera Biologics Inc (ABCL-Q) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

Palantir Technologies Inc Cl A (PLTR-N) QuotePress Release - The Globe and Mail

Nov 07, 2024

Nov 07, 2024

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024 - Business Wire

Nov 07, 2024

Nov 07, 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Just Reported And Analysts Have Been Cutting Their Estimates - Simply Wall St

Nov 07, 2024

Nov 07, 2024

Leerink Partnrs Has Pessimistic View of ABCL FY2024 Earnings - MarketBeat

Nov 07, 2024

Nov 07, 2024

AbCellera Unveils Breakthrough T-Cell Platform Data, Shows Promise in Cancer Treatment - StockTitan

Nov 07, 2024

Nov 06, 2024

AbCellera Biologics Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

Nov 06, 2024

Nov 05, 2024

AbCellera Biologics (NASDAQ:ABCL) Given "Hold" Rating at Benchmark - MarketBeat

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics (NASDAQ:ABCL) Given "Buy" Rating at Stifel Nicolaus - MarketBeat

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics (NASDAQ:ABCL) Shares Gap Down After Earnings Miss - MarketBeat

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics (NASDAQ:ABCL) Posts Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat

Nov 05, 2024

Nov 05, 2024

AbCellera stock price target cut, keeps Outperform on strategic pivot By Investing.com - Investing.com UK

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc. (ABCL) Reports Q3 Loss, Misses Revenue Estimates - MSN

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada

Nov 05, 2024

Nov 05, 2024

Earnings call: AbCellera reports steady Q3 2024 revenue amidst R&D growth - Investing.com

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance

Nov 05, 2024

Nov 05, 2024

AbCellera Biologics Inc (ABCL) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic Developments - GuruFocus.com

Nov 05, 2024

Nov 04, 2024

AbCellera Reports Q3 2024 Business Results - The Globe and Mail

Nov 04, 2024

Nov 04, 2024

AbCellera Biologics Reports Q3 2024 Financial Results - TipRanks

Nov 04, 2024

Nov 04, 2024

AbCellera Biologics (ABCL) Q3 2024 Earnings Call Transcript - Nasdaq

Nov 04, 2024

Nov 04, 2024

Nasdaq Insurance Index (INSR) QuotePress Release - The Globe and Mail

Nov 04, 2024

Nov 04, 2024

TSX Industrials Capped Index (TTIN) QuotePress Release - The Globe and Mail

Nov 04, 2024

Nov 04, 2024

Abcellera Biologics earnings beat, revenue fell short of estimates By Investing.com - Investing.com UK

Nov 04, 2024